Effect And Optimization Of Kangmei Pharmaceutical Asset-light Profit Model From The Perspective Of The Whole Chain

In recent years,with the increasing demand of pharmaceutical market and the intensification of product quality competition among enterprises,international pharmaceutical giants have begun to merge and expand.In order to compensate for the long period of drug research and development,large investment in the middle stages of development and high operational risk,the asset-light profit model emerged as the times require.The asset-light profit model is a kind of profit mode,which takes less investment.In essence,it uses leverage resources to pry the high-profit links in the value chain and gradually form the core competitiveness of enterprises.Since the 19 th century,people have always been enthusiastic about the study of the asset-light profit model,and many achievements have been made in the academic circles.Among them,the study of the asset-light profit model by western scholars is relatively perfect,and the practical application based on a single case is more extensive.Relatively speaking,the combination of theoretical research and practice of the asset-light profit model in China is still weak,especially the evaluation and analysis of the financial performance and non-financial performance of the asset-light profit model are rarely studied.In addition,in order to adapt to the changing global economic environment,many enterprises no longer rely on the expansion of market share,and some pharmaceutical enterprises are beginning to focus on the development of marketing capabilities,R&D capabilities,value chain management and other light assets.However,the pharmaceutical industry chain is lengthy,and the parts in the industry chain are closely linked,so it is particularly important to build the whole industry chain.Kangmei Pharmaceutical Industry is one of the typical ones.Therefore,this paper selects Kangmei Pharmaceutical Industry as the object,combined with its characteristics as a pharmaceutical enterprise with asset-light profit model,through theoretical analysis based on asset-light profit model,assessing the effect of the asset-light profit model from the perspective of the whole industry chain,and points out the problems of the asset-light profit model from the perspective of the whole industry chain,and puts forward optimization suggestions for its problems.At the same time,through the analysis of the effect of asset-light profit model,combined with the industry background,further thinking about whether the asset-light profit model enterprises can adapt to the sustainable development of the industry,whether the construction of the whole industry chain can achieve synergistic effect in the pharmaceutical industry.Based on the theory of smile curve and the actual situation of Kangmei Pharmaceutical Industry,this paper adopts several research methods,such as case analysis,literature research,financial analysis and summarizing,to study the effect of Kangmei Pharmaceutical asset-light profit model from the perspective of the whole industry chain.First of all,this paper divides the research categories of light asset,combining the case,based on the characteristics and financial performance of light assets enterprises,using qualitative analysis to identify the light asset resources involved in this article,determining the existence of light assets resources of this paper.Secondly,we read and study the relevant literature on the profit model of light assets,summarize the research results of scholars on the performance of the asset-light profit model,and determine the index system of performance analysis in this case.Thirdly,using quantitative analysis methods such as financial ratio analysis and model study,combined with all links of Kangmei Pharmaceutical Industry chain,this paper analyzed the implementation effect of the asset-light profit model from the industrial chain,middle and lower links.Finally,combined with external financing,medicinal plant,hospital mergers and acquisitions and other acts,the existing problems of the asset-light profit model are summarized,and optimization suggestions are put forward.The structure of this paper consists of six parts.The first chapter is the introduction,which summarizes the writing background,significance,train of thought and application of research methods,and summarizes the existing research results domestic and abroad.The second chapter is the theoretical overview of this article.Firstly,it briefly explains the characteristics,advantages and disadvantages of the asset-light profit model and the related concepts of the whole industry chain.Secondly,it explains the reasons for choosing the asset-light profit model.Finally,it elaborates how to establish the index evaluation system of the asset-light profit model from the perspective of the whole industry chain and introduces the relevant theoretical basis.The third chapter mainly introduces the cases selected in this paper.Firstly,the basic situation of Kangmei Pharmaceutical Industry and the composition of its industrial chain are explained.Secondly,according to the actual situation of Kangmei Pharmaceutical Industry,the characteristics of its asset-light profit model and the integration of the industrial chain are explained in detail.Finally,the motivation of Kangmei Pharmaceutical Industry to choose the asset-light profit model is summarized.The forth chapter is a specific analysis of the effect of Kangmei Pharmaceutical Industry asset-light profit model from the perspective of the whole industry chain.Firstly,based on the synergy effect of operation,management and finance of industry chain,the financial effect of enterprise asset-light profit model is quantitatively analyzed by combining financial statement analysis and financial index analysis.Secondly,the non-financial effect of the asset-light profit model is further explored according to the different stages of the industrial chain.Finally,under the background of the whole industry chain,the value creation path of he asset-light profit model is discussed.The fifth chapter is to put forward the problems based on the analysis results.Focusing on its interest-bearing liability ratio,expendable biological assets management and expansion of medical services,this paper puts forward optimization suggestions from the practical point of view.The sixth chapter is the conclusion and Enlightenment of this paper,and also the content of the last chapter.